C22orf31 Antikörper (Biotin)

Produktnummer ABIN1400683

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch C22orf31 in WB und IHC (p). Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für C22orf31 Antikörper (Biotin) (ABIN1400683)

Target: C22orf31 (Chromosome 22 Open Reading Frame 31 (C22orf31))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser C22orf31 Antikörper ist konjugiert mit Biotin

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Produktdetails anti-C22orf31 Antikörper (Biotin)

Kreuzreaktivität: Human

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human C22orf31

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
IHC-P 1:200-400

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Details zu C22orf31

Target: C22orf31 (Chromosome 22 Open Reading Frame 31 (C22orf31))

Andere Bezeichnung: C22orf31

Hintergrund:

Synonyms: HS747E2A, bK747E2.1, C22orf31, Chromosome 22 open reading frame 31, HS747E2A, Hypothetical protein LOC25770, CV031_HUMAN.

Background: C22orf31, also known as HS747E2A or bK747E2.1, is a 290 amino acid protein encoded by a gene located on human chromosome 22, which contains over 500 genes and about 49 million bases. As the second smallest human chromosome, chomosome 22 contains a wide variety of genes with numerous functions. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia.

Gen-ID: 25770